Overview

PMS of Trazenta on the Long-term Use as Add-on Therapy

Status:
Completed
Trial end date:
2018-10-04
Target enrollment:
Participant gender:
Summary
Study to investigate the safety and efficacy of long-term daily use of Trazenta® Tablets as add-on therapy in patients with type 2 diabetes mellitus.
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborator:
Eli Lilly and Company